Advertisement

Is the Late Outcome of Heart Valve Replacement Influenced by the Hemodynamics of the Heart Valve Substitute?

  • Dieter Horstkotte
  • F. Loogen
  • W. Bircks
Conference paper

Abstract

Although many of the problems of the early years of heart valve replacement seem to be solved, other problems still remain. For example, the high operative mortality of the early years has decreased to less than 5% (1); today operative long-term complications (2) and insufficient recovery from preoperative myocardial dysfunction (3) are of much more concern.

Keywords

Valve Replacement Pulmonary Artery Pressure Mitral Valve Replacement Jude Medical Prosthetic Valve Endocarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rodewald GM, Polonius MJ (1984) Cardiac surgery in the Federal Republic of Germany during 1983. A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 32: 395Google Scholar
  2. 2.
    Horstkotte D, Körfer R, Seipel L et al (1983) Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation 68 (Suppl II): 175Google Scholar
  3. 3.
    Mehmel HC, Hasper B, Zebe H et al (1978) Die linksventrikuläre Funktion bei Aortenklappenstenose und -insuffizienz präoperativ und nach prothetischem Herzklappenersatz. Z Kardiol 67: 242PubMedGoogle Scholar
  4. 4.
    MacManus Q, Grunkemeier GL, Lambert LE al (1980) Year of operation as a risk factor in the late results of valve replacement. J Thorac Cardiovasc Surg 80: 834PubMedGoogle Scholar
  5. 5.
    Horstkotte D, Haerten, K, Krian A (1983) Der prothetische Herzklappenersatz: Natürlicher Verlauf operationswürdiger Herzklappenfehler. Möglichkeiten und klinische Ergebnisse der operativen Behandlung. Int Welt 6: 137Google Scholar
  6. 6.
    Horstkotte D, Haerten K, Seipel L et al (1983) Central hemodynamics at rest and during exercise after mitral valve replacement with different prostheses. Circulation 68 (Suppl II): 161Google Scholar
  7. 7.
    New York Heart Association (1964) The Criteria Committee of the New York Heart Association: Disease of the heart and blood vessels (nomenclature and criteria for diagnosis). Little Brown, BostonGoogle Scholar
  8. 8.
    Haerten K (1981) Möglichkeiten and Grenzen des prothetischen Herzklappenersatzes. Enke, Stuttgart, p 32Google Scholar
  9. 9.
    Kraus F, Rudolph W (1984) Symptoms, exercise capacity and exercise hemodynamics: Interrelationship and their role in quantification of valvular lesions. Herz 9: 187Google Scholar
  10. 10.
    Horstkotte D, Haerten K, Herzer JA et al (1983) Five-year results after randomized mitral valve replacement with Björk-Shiley, Lillehei-Kaster, and Starr-Edwards prostheses. Thorac Cardiovasc Surg 31: 206Google Scholar
  11. 11.
    Nowacki PE (1975) Der Wirkungsgrad bei ergometrischer Leistung. In: Mellerowicz H, Jokl E, Hansen G (eds) Ergebnisse der Ergometrie. Perimed, Erlangen, p 73Google Scholar
  12. 12.
    Carstens V, Behrenbeck DW, Higer HH (1983) Exercise capacity before and after cardiac valve surgery. Cardiology 70: 41PubMedCrossRefGoogle Scholar
  13. 13.
    Führe U, Both A, Fischer G et al (1977) Evaluation of social status and hemodynamic results four to six years after prosthetic valve replacement. Z Kardiol 66: 251Google Scholar
  14. 14.
    Horstkotte D, Schulte HD, Körfer R et al (1982) Mitral valve replacement using different prosthetic valves. Int J Artif Organs 5: 177PubMedGoogle Scholar
  15. 15.
    Horstkotte D, Haerten K, Körfer R et al (1983) Hemodynamic findings at rest and during exercise after implantation of different aortic valve prostheses. Z Kardiol 72: 429PubMedGoogle Scholar
  16. 16.
    Sigwart U, Schmidt H, Gleichmann U et al (1976) In-vivo evaluation of the Lillehei-Kaster heart valve prosthesis. Ann Thorac Surg 22: 213PubMedCrossRefGoogle Scholar
  17. 17.
    Ohlmeier, H, Mannebach H, Greitemeier A (1982) Clinical follow-up of patients after valve replacement with Omniscience cardiac valves: Can this valve be recommended? Z Kardiol 71: 350PubMedGoogle Scholar
  18. 18.
    Horstkotte D, Haerten K, Schulte HD et al (1983) Hemodynamic findings at rest and during exercise after implantation of different mitral valve prostheses with equal tissue annulus diameter. Z Kardiol 72: 385PubMedGoogle Scholar
  19. 19.
    Huhmann W, Köhler J Opening areas of arteficial valves. Z Kardiol 67: 672Google Scholar
  20. 20.
    Roberts WC (1976) Choosing a substitute cardiac valve. Type, size, surgeon. Am J Cardiol 38: 633PubMedCrossRefGoogle Scholar
  21. 21.
    Burch GE, Giles TD (1974) Clinical evaluation of aortic and mitral valve prostheses. Am Heart J 92: 245CrossRefGoogle Scholar
  22. 22.
    Horstkotte D, Körfer R, Loogen F et al (1984) Prosthetic valve endocarditis: Clinical findings and management. Eur Heart J 5 (Suppl C): 117PubMedCrossRefGoogle Scholar
  23. 23.
    Horstkotte D, Körfer R, Budde Th et al (1983) Late complications following Björk-Shiley and St. Jude Medical heart valve replacement. Z Kardiol 72: 251Google Scholar
  24. 24.
    Horstkotte D, Haerten K, Leuner Ch et al (1978) Chronic intravascular hemolysis following mitral valve replacement with Björk-Shiley, Lillehei-Kaster, and Starr-Edwards prostheses. Z Kardiol 67: 629Google Scholar
  25. 25.
    Horstkotte D, Aul C, Seipel L et al (1983) Influence of valve type and valve functoin on chronic intravascular hemolysis following mitral and aortic valve replacement using alloprostheses. Z Kardiol 72: 119PubMedGoogle Scholar
  26. 26.
    Akutsu T, Modi VJ (1982) Fluid dynamics of several mechanical prosthetic heart valves using laser Doppler anemometer. Life Supp Syst, Proceedings IX Meeting ESAO: 102Google Scholar
  27. 27.
    Gentle CR (1982) Characterisation of leakage flow in cardiac valve prostheses. Life Supp Syst, Proceedings IX. Ann Meeting ESAO: 102Google Scholar
  28. 28.
    Heilmann E, Ritzenhöfer A, Achatzky et al (1978) Haptoglobin and Transferin nach künstlichem Herzklappenersatz. Herz/Kreisl 10: 84Google Scholar
  29. 29.
    Szekely P (1964) Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Heart J 1964 /1: 1209Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Dieter Horstkotte
    • 1
  • F. Loogen
  • W. Bircks
  1. 1.Medizinische KlinikUniversität DüsseldorfDüsseldorfGermany

Personalised recommendations